Patents by Inventor Ralf Jochem

Ralf Jochem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8282943
    Abstract: The invention is relates to drugs on the basis of antibodies against non-cellular bone matrix proteins, especially BSP, for use in the prevention and treatment of bone metastases. According to the invention, the antibodies are induced in the patient by recombinantly expressing antigenic determinants of bone matrix proteins in Listeria and anchoring them on the surfaces thereof. The antigenic determinants are selected according to whether they are characteristic of antigens that are expressed by the tumor cells themselves.
    Type: Grant
    Filed: May 31, 2006
    Date of Patent: October 9, 2012
    Inventors: Ralf Jochem, Franz Paul Armbruster, Veit Braun, Christoph Von Eichel-Streiber
  • Publication number: 20090220517
    Abstract: The present invention relates to a method for producing carrier microorganisms, in particular bacteria, which, through targeted genetic manipulation, carry epitopes or epitomers, respectively, on their surfaces. Epitomers are antigenically effective epitopes that can be found in the polypeptide chain in multiple identical copies, and which, when expressed on the surface of the bacteria, can be used for immunization with particular success. A further aspect relates to correspondingly produced bacteria and their uses as vaccines, in particular in cancer therapy.
    Type: Application
    Filed: November 29, 2006
    Publication date: September 3, 2009
    Applicant: tgcBIOMICS GmbH
    Inventors: Veit Braun, Christoph Von Eichel-Streiber, Ralf Jochem
  • Publication number: 20090142372
    Abstract: The invention is relates to drugs on the basis of antibodies against non-cellular bone matrix proteins, especially BSP, for use in the prevention and treatment of bone metastases. According to the invention, the antibodies are induced in the patient by recombinantly expressing antigenic determinants of bone matrix proteins in Listeria and anchoring them on the surfaces thereof. The antigenic determinants are selected according to whether they are characteristic of antigens that are expressed by the tumor cells themselves.
    Type: Application
    Filed: May 31, 2006
    Publication date: June 4, 2009
    Inventors: Ralf Jochem, Franz Paul Armbruster, Veit Braun, Christoph Von Eichel-Streiber